AngioDynamics fiscal Q3 operating income drops 257%; Guidance lowered

|By:, SA News Editor

AngioDynamics (NASDAQ:ANGO) fiscal Q3 results ($M): Revenues: 86.6 (-1.8%); Operating Expenses: 48.0 (+25.3%); Operating Loss: (10.2) (-256.9%); Net Loss: (4.3) (-195.6%); Loss Per Share: (0.12) (-192.3%); Quick Assets: 21.4 (+19.6%); CF Ops: 12.2 (+999%).

Sales by Product Category: Peripheral Vascular: 46.2 (-2.5%); Vascular Access: 26.4 (-3.3%); Oncology/Surgery: 13.1 (+9.2%).

Fiscal Q4 Guidance: Revenues: $90M - 94M; Non-GAAP EPS: $0.13 - 0.16.

Fiscal 2015 Guidance: Revenues: $356M - 360M from $362M - 368M; Non-GAAP EPS: $0.57 - 0.60 from $0.66 - 0.72.

Subscribe for full text news in your inbox